111 related articles for article (PubMed ID: 7883225)
21. The use of caffeine as a metabolic probe for human drug metabolizing enzymes.
Miners JO; Birkett DJ
Gen Pharmacol; 1996 Mar; 27(2):245-9. PubMed ID: 8919637
[TBL] [Abstract][Full Text] [Related]
22. The in-vivo effect of bakumondo-to (TJ-29), a traditional Japanese medicine used for treatment of chronic airway disease, on cytochrome P450 1A2, xanthine oxidase and N-acetyltransferase 2 activity in man.
Saruwatari J; Hisaeda S; Higa Y; Tomiyasu Y; Nakagawa K; Ishizaki T
J Pharm Pharmacol; 2004 Sep; 56(9):1171-7. PubMed ID: 15324486
[TBL] [Abstract][Full Text] [Related]
23. Feasibility of laparoscopic total proctocolectomy with ileal pouch-anal anastomosis and total colectomy with ileorectal anastomosis for familial adenomatous polyposis: results of a nationwide multicenter study.
Konishi T; Ishida H; Ueno H; Kobayashi H; Hinoi T; Inoue Y; Ishida F; Kanemitsu Y; Yamaguchi T; Tomita N; Matsubara N; Watanabe T; Sugihara K
Int J Clin Oncol; 2016 Oct; 21(5):953-961. PubMed ID: 27095110
[TBL] [Abstract][Full Text] [Related]
24. [Determination of caffeine metabolite for the evaluation of N-acetyltransferase, CYP1A2 and xanthine oxidase activities].
Lu JF; Yi T; Cao XM; Zhuo HT; Ling SS
Yao Xue Xue Bao; 1997 Nov; 32(11):813-8. PubMed ID: 11596199
[TBL] [Abstract][Full Text] [Related]
25. [Diagnosis and treatment of familial adenomatous polyposis].
Li Y; Song S; Jiang Y
Zhonghua Wai Ke Za Zhi; 1999 Jun; 37(6):328-30. PubMed ID: 11829850
[TBL] [Abstract][Full Text] [Related]
26. Variability in caffeine metabolism.
Grant DM; Tang BK; Kalow W
Clin Pharmacol Ther; 1983 May; 33(5):591-602. PubMed ID: 6687705
[TBL] [Abstract][Full Text] [Related]
27. Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities.
Kalow W; Tang BK
Clin Pharmacol Ther; 1991 Nov; 50(5 Pt 1):508-19. PubMed ID: 1934864
[TBL] [Abstract][Full Text] [Related]
28. [Preventive surgery for familial adenomatous polyposis coli].
Kadmon M
Chirurg; 2005 Dec; 76(12):1125-34. PubMed ID: 16323029
[TBL] [Abstract][Full Text] [Related]
29. Determination of Urinary Caffeine Metabolites as Biomarkers for Drug Metabolic Enzyme Activities.
Kim HJ; Choi MS; Rehman SU; Ji YS; Yu JS; Nakamura K; Yoo HH
Nutrients; 2019 Aug; 11(8):. PubMed ID: 31430927
[TBL] [Abstract][Full Text] [Related]
30. Effect of St John's wort on the activities of CYP1A2, CYP3A4, CYP2D6, N-acetyltransferase 2, and xanthine oxidase in healthy males and females.
Wenk M; Todesco L; Krähenbühl S
Br J Clin Pharmacol; 2004 Apr; 57(4):495-9. PubMed ID: 15025748
[TBL] [Abstract][Full Text] [Related]
31. Capsule endoscopy is useful and safe for small-bowel surveillance in familial adenomatous polyposis.
Iaquinto G; Fornasarig M; Quaia M; Giardullo N; D'Onofrio V; Iaquinto S; Di Bella S; Cannizzaro R
Gastrointest Endosc; 2008 Jan; 67(1):61-7. PubMed ID: 18155426
[TBL] [Abstract][Full Text] [Related]
32. Risk of desmoid tumours after open and laparoscopic colectomy in patients with familial adenomatous polyposis.
Vitellaro M; Sala P; Signoroni S; Radice P; Fortuzzi S; Civelli EM; Ballardini G; Kleiman DA; Morrissey KP; Bertario L
Br J Surg; 2014 Apr; 101(5):558-65. PubMed ID: 24493089
[TBL] [Abstract][Full Text] [Related]
33. Endoscopic management of familial adenomatous polyposis in patients refusing colectomy.
Ishikawa H; Mutoh M; Iwama T; Suzuki S; Abe T; Takeuchi Y; Nakamura T; Ezoe Y; Fujii G; Wakabayashi K; Nakajima T; Sakai T
Endoscopy; 2016 Jan; 48(1):51-5. PubMed ID: 26352809
[TBL] [Abstract][Full Text] [Related]
34. Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene.
Nakajima M; Yokoi T; Mizutani M; Shin S; Kadlubar FF; Kamataki T
Cancer Epidemiol Biomarkers Prev; 1994; 3(5):413-21. PubMed ID: 7920209
[TBL] [Abstract][Full Text] [Related]
35. Activities of cytochrome P450 1A2, N-acetyltransferase 2, xanthine oxidase, and cytochrome P450 2D6 are unaltered in children with cystic fibrosis.
Kennedy MJ; Scripture CD; Kashuba AD; Scott CS; Gaedigk A; Kearns GL
Clin Pharmacol Ther; 2004 Mar; 75(3):163-71. PubMed ID: 15001967
[TBL] [Abstract][Full Text] [Related]
36. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
[TBL] [Abstract][Full Text] [Related]
37. Current status of prophylactic surgical treatment for familial adenomatous polyposis in Japan.
Yamadera M; Ueno H; Kobayashi H; Konishi T; Ishida F; Yamaguchi T; Hinoi T; Inoue Y; Kanemitsu Y; Tomita N; Ishida H; Sugihara K
Surg Today; 2017 Jun; 47(6):690-696. PubMed ID: 27770209
[TBL] [Abstract][Full Text] [Related]
38. Rectal mucosal ornithine decarboxylase activity in familial adenomatous polyposis after ileorectal anastomosis.
Patchett SE; Alstead EM; Trzeciak L; Wocial T; Phillips RK; Farthing MJ
Gut; 1994 Nov; 35(11):1624-6. PubMed ID: 7828986
[TBL] [Abstract][Full Text] [Related]
39. Small-intestinal involvement in familial adenomatous polyposis: evaluation by double-balloon endoscopy and intraoperative enteroscopy.
Matsumoto T; Esaki M; Yanaru-Fujisawa R; Moriyama T; Yada S; Nakamura S; Yao T; Iida M
Gastrointest Endosc; 2008 Nov; 68(5):911-9. PubMed ID: 18561922
[TBL] [Abstract][Full Text] [Related]
40. Laparoscopic total colectomy and ileorectal anastomosis (IRA), supported by an enhanced recovery programme in cases of familial adenomatous polyposis.
McNicol FJ; Kennedy RH; Phillips RK; Clark SK
Colorectal Dis; 2012 Apr; 14(4):458-62. PubMed ID: 21689351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
